Author(s): Bishop Adhikari, D. Nagasamy Venkatesh

Email(s): nagasamyvenkatesh@jssuni.edu.in

DOI: 10.52711/0974-360X.2025.00721   

Address: Bishop Adhikari1, D. Nagasamy Venkatesh2*
1Department of Pharmaceutical Regulatory Affairs, JSS College of Pharmacy (JSS Academy of Higher Education and Research, Mysuru), Ooty – 643 001. The Nilgiris. Tamil Nadu. India.
2Department of Pharmaceutics, JSS College of Pharmacy (JSS Academy of Higher Education and Research, Mysuru), Ooty – 643 001. The Nilgiris. Tamil Nadu. India.
*Corresponding Author

Published In:   Volume - 18,      Issue - 10,     Year - 2025


ABSTRACT:
Good Manufacturing Practices (GMP) play a critical part in ensuring the quality, safety, and efficacity of nutraceutical products during their manufacturing process. This abstract provides an overview of the significance of GMP in enhancing conditions for nutraceutical products. It highlights crucial rudiments of GMP, including installation design and conservation, labor force training and qualifications, raw material sourcing, and control, manufacturing processes and controls, packaging and labeling, and quality control and testing procedures. The epitome also discusses the challenges and considerations in enforcing GMP in nutraceutical manufacturing, along with strategies for successful perpetration and compliance. Also, it explores advances in GMP, similar to emerging technologies and inventions, and the integration of quality operating systems and robotization for better effectiveness and safety. Likewise, this emphasizes the significance of routine GMP checkups and examinations to ensure compliance and provides best practices for preparing and navigating examinations. Incipiently, it presents unborn perspectives and recommendations for further enhancing product safety and consumer health through ongoing advancements in nutraceutical GMP. Overall, this underscores the pivotal part of GMP in elevating the norms and conditions for nutraceutical products, eventually contributing to the production of high-quality and safe nutraceutical products.


Cite this article:
Bishop Adhikari, D. Nagasamy Venkatesh. Promoting Innovation in The Production of Nutraceuticals: An Examination of Improved Good Manufacturing Practices in Markets That are Regulated or Not. Research Journal of Pharmacy and Technology. 2025;18(10):4990-8. doi: 10.52711/0974-360X.2025.00721

Cite(Electronic):
Bishop Adhikari, D. Nagasamy Venkatesh. Promoting Innovation in The Production of Nutraceuticals: An Examination of Improved Good Manufacturing Practices in Markets That are Regulated or Not. Research Journal of Pharmacy and Technology. 2025;18(10):4990-8. doi: 10.52711/0974-360X.2025.00721   Available on: https://rjptonline.org/AbstractView.aspx?PID=2025-18-10-60


REFERENCES: 
1.    Chopra AS, Lordan R, Horbańczuk OK, Atanasov AG, Chopra I, Horbańczuk JO, et al. The current use and evolving landscape of nutraceuticals. Pharmacol Res. 2022; 175: 106001.
2.    Namdeo Shinde, Bhaskar Bangar, Sunil Deshmukh, Pratik Kumbhar. Nutraceuticals: A Review on current status. Research J. Pharm. and Tech. 2014; 7(1): 110-113.
3.    A Rajasekaran, G Sivagnanam, R Xavier. Nutraceuticals as therapeutic agents: A Review. Research J. Pharm. and Tech. 2008; 1(4): 171-174.
4.    Sanjay Kumar Jain, Rajesh Kumar Jain. Evolution of GMP in the Pharmaceutical Industry. Research J. Pharm. and Tech. 2017; 10(2): 601-606. doi: 10.5958/0974-360X.2017.00118.4.
5.    Anali Sawant, Seema Kamath, Hemanth Katta G, Muddukrishna Badamane Sathyanarayana, Ravindra Shenoy, Girish Pai K . Investigation of manufacturing defects and cGMP lessons learned from quality issues in Pharmaceutical Sterile Preparations. Research Journal of Pharmacy and Technology. 2022; 15(2):729-5. doi: 10.52711/0974-360X.2022.00121.
6.    Fabio, P., Alessandro, C., Stefania, S., Iolanda, G., Elena, M., and Aldo, C. The requirements for manufacturing highly active or sensitizing drugs comparing Good Manufacturing Practices. Acta Bio Medica: Atenei Parmensis.2019; 90(2): 288.
7.    Allison, G., Cain, Y. T., Cooney, C., Garcia, T., Bizjak, T. G., Holte, O., et al. Regulatory and quality considerations for continuous manufacturing. May 20–21, 2014 continuous manufacturing symposium. Journal of Pharmaceutical Sciences. 2015; 104(3): 803-812.
8.    Sarika S. Lokhande. Role of Nutraceuticals in Various Diseases: A Comprehensive Review. Asian J. Pharm. Res. 2018; 8(4): 236-240. doi: 10.5958/2231-5691.2018.00040.0.
9.    Sneha Mali, Sanket Rathod, Niraj Kale, Namdeo Shinde. Overview of Nutraceuticals. Asian Journal of Pharmaceutical Research. 2022; 12(1): 61-0. doi: 10.52711/2231-5691.2022.00010.
10.    Blanchfield, J. R. Good manufacturing practice (GMP) in the food industry. In Handbook of hygiene control in the food industry. 2005 (pp. 324-347). Woodhead Publishing.
11.    Seema Thakur, Neha Srivastava. Nutraceuticals: A Review. Asian J. Res. Pharm. Sci. 2016; 6(2): 85-94. doi: 10.5958/2231-5659.2016.00012.6
12.    Burdock, G. A., Carabin, I. G., and Griffiths, J. C. The importance of GRAS to the functional food and nutraceutical industries. Toxicology. 2006; 221(1): 17-27.
13.    Kang, J., and Hustvedt, G. Building trust between consumers and corporations: The role of consumer perceptions of transparency and social responsibility. Journal of business ethics. 2014; 125, 253-265.
14.    Hock, S. C., Kian, S. M., and Wah, C. L. Global challenges in the manufacture, regulation and international harmonization of GMP and quality standards for biopharmaceuticals. Generics and Biosimilars Initiative Journal. 2020; 9(2): 52-64.
15.    Rmmding, F. Tried and True Method. Link: https://naldc.nal.usda.gov/download/IND87016236/pdf.
16.    Santini, A., Cammarata, S. M., Capone, G., Ianaro, A., Tenore, G. C., Pani, L., and Novellino, E. Nutraceuticals: Opening the debate for a regulatory framework. British Journal of Clinical Pharmacology. 2018; 84(4): 659-672.
17.    Bretaudeau, L., Tremblais, K., Aubrit, F., Meichenin, M., and Arnaud, I. Good manufacturing practice (GMP) compliance for phage therapy medicinal products. Frontiers in Microbiology. 2020; 11, 1161.
18.    Bust, L. Importance of documentation in GMP. ISBT Science Series. 2013; 8(1): 16-18.
19.    Sikora, T. Good manufacturing practice (GMP) in the production of dietary supplements. In Dietary Supplements. 2015; (pp. 25-36). Woodhead Publishing.
20.    DeFelice, S. L. The nutraceutical revolution: its impact on food industry R and D. Trends in Food Science and Technology. 1995; 6(2): 59-61.
21.    Keservani, R. K., Kesharwani, R. K., Vyas, N., Jain, S., Raghuvanshi, R., and Sharma, A. K. Nutraceutical and functional food as future food: a review. Der Pharmacia Lettre. 2010; 2(1): 106-116.
22.    Kottke, M. K. (1998). Scientific and regulatory aspects of nutraceutical products in the United States. Drug development and industrial pharmacy, 24(12): 1177-1195.
23.    Shinde, N., Bangar, B., Deshmukh, S., and Kumbhar, P. Nutraceuticals: A Review on current status. Research Journal of Pharmacy and Techznology. 2014; 7(1): 110-113.
24.    Petkova-Gueorguieva, E. S., Getov, I. N., Ivanov, K. V., Ivanova, S. D., Gueorguiev, S. R. et al. Regulatory requirements for food supplements in the European Union and Bulgaria. Folia medica,2019; 61: 37.
25.    Silano, V., Coppens, P., Larrañaga-Guetaria, A., Minghetti, P., and Roth-Ehrang, R. Regulations applicable to plant food supplements and related products in the European Union. Food and function. 2011; 2(12): 710-719.
26.    Nestmann, E. R., Harwood, M., and Martyres, S. An innovative model for regulating supplement products: natural health products in Canada. Toxicology. 2006; 221(1): 50-58.
27.    Fitzpatrick, K. Regulatory issues related to functional foods and natural health products in Canada. Regulation of Functional Foods and Nutraceuticals: A Global Perspective. 2005; 213-226.
28.    Smith, A., Jogalekar, S., and Gibson, A. Regulation of natural health products in Canada. Journal of Ethnopharmacology. 2014; 158, 507-510.
29.    Harrison, J. R., and Nestmann, E. R. Current Canadian regulatory initiatives and policies for natural health products (dietary supplements). In Nutraceutical and Functional Food Regulations in the United States and Around the World. 2014; (pp. 183-200). Academic Press.
30.    Blaze, J. A comparison of current regulatory frameworks for nutraceuticals in Australia, Canada, Japan, and the United States. Innovations in Pharmacy. 2021; 12(2).
31.    Daliri, E. B. M., and Lee, B. H. Current trends and future perspectives on functional foods and nutraceuticals. Beneficial microorganisms in food and nutraceuticals. 2015; 221-244.
32.    Umegaki, K. Regulatory aspects of nutraceuticals: a Japanese perspective. In Nutraceuticals.2021; (pp. 1299-1307). Academic Press.
33.    Mishra, S. S., Behera, P. K., Kar, B., and Ray, R. C. Advances in probiotics, prebiotics and nutraceuticals. Innovations in technologies for fermented food and beverage industries. 2018; 121-141.
34.    Chen, J. Regulatory control of Functional Food in China. Scandinavian Journal of Nutrition/Naringsforskning. 2000; 44(3), 130-131.
35.    Sun, J. The Regulation of" Novel Food" in China: the Tendency of Deregulation. European Food and Feed Law Review. 2015; 442-448.
36.    Huang, G., and Lapsley, K. Chinese health (functional) food regulations. Regulation of Functional Foods and Nutraceuticals: A Global Perspective. 2005; 263-291.
37.    Tam, W., and Yang, D. Food safety and the development of regulatory institutions in China. Asian Perspective. 2005; 29(4): 5-36.
38.    Chen, K., Wang, X. X., and Song, H. Y. Food safety regulatory systems in Europe and China: A study of how co-regulation can improve regulatory effectiveness. Journal of Integrative Agriculture. 2015; 14(11): 2203-2217.
39.    Zawistowski, J. Regulation of functional foods in selected Asian countries in the Pacific rim. In Nutraceutical and Functional Food Regulations in the United States and Around the World.2008; (pp. 365-401). Academic Press.
40.    Mtewa, A. G., Chikowe, I., Kumar, S., Ngwira, K. J., and Lampiao, F. Good manufacturing practices and safety issues in functional food industries. Functional Foods and Nutraceuticals: Bioactive Components, Formulations and Innovations.2020; 613-628. 
41.    Lincoln, J. E. Overview of the US FDA GMPS: Good manufacturing practice (GMP)/quality system (qs) regulation (21 CFR part 820). Journal of Validation Technology. 2021; 18(3): 17.
42.    Marucheck, A., Greis, N., Mena, C., and Cai, L. Product safety and security in the global supply chain: Issues, challenges, and research opportunities. Journal of Operations Management. 2011; 29(7-8): 707-720.
43.    Ehsan, A. H. Halal Nutraceutical Market: Issues and Challenges. In AFBE 2008 Conference Papers (p. 573).
44.    Veeman, M. Policy development for novel foods: issues and challenges for functional food. Canadian Journal of Agricultural Economics/Revue Canadienne d'agroeconomie. 2002; 50(4): 527-539.
45.    Gershwin, M. E., Borchers, A. T., Keen, C. L., Hendler, S., Hagie, F., and Greenwood, M. R. C. Public safety and dietary supplementation. Annals of the New York Academy of Sciences. 2010; 1190(1): 104-117.
46.    Souto, E. B., Silva, G. F., Dias-Ferreira, J., Zielinska, A., Ventura, F., Durazzo, A., ... and Santini, A. Nanopharmaceutics: Part I—Clinical trials legislation and good manufacturing practices (GMP) of nanotherapeutics in the EU. Pharmaceutics. 2020; 12(2): 146.
47.    Dureja, H., Kaushik, D., and Kumar, V. Developments in nutraceuticals. Indian Journal of Pharmacology. 35(6), 363-372.
48.    Zeisel, S. H. (1999). Regulation of" nutraceuticals". Science. 2003; 285(5435): 1853-1855.
49.    Ochotny, M. N., Partney, T. N., and Pathak, Y. V. Evidence-Based Approach and Standardization of Nutraceuticals. GSTF Journal of Advances in Medical Research (JAMR).2014; 1, 1-3.
50.    Puttasiddaiah, R., Lakshminarayana, R., Somashekar, N. L., Gupta, V. K., Inbaraj, B. S., Usmani, Z., et al. Advances in nanofabrication technology for nutraceuticals: New insights and future trends. Bioengineering. 2022; 9(9): 478.
51.    Alonso-Alonso, M., Woods, S. C., Pelchat, M., Grigson, P. S., Stice, E., Farooqi, S., ... and Beauchamp, G. K. Food reward system: current perspectives and future research needs. Nutrition reviews.2015; 73(5), 296-307.
52.    Wechsler, J. Data integrity key to GMP compliance. BioPharm International. 2014; 27(9).
53.    Cicero, A. F., and Rizzo, M. Future Perspectives in Nutraceutical Research. Nutraceuticals and Cardiovascular Disease: An Evidence-based Approach for Clinical Practice. 2021; 289-293.
54.    Daliu, P., Santini, A., and Novellino, E. A decade of nutraceutical patents: where are we now in 2018? Expert opinion on therapeutic patents. 2018; 28(12): 875-882.
55.    Yang, M. S. Regulatory aspects of nutraceuticals: Chinese perspective. In Nutraceuticals. 2016. (pp. 947-957). Academic Press.
56.    He, T. T., Ung, C. O. L., Hu, H., and Wang, Y. T. Good manufacturing practice (GMP) regulation of herbal medicine in comparative research: China GMP, cGMP, WHO-GMP, PIC/S and EU-GMP. European Journal of Integrative Medicine. 2015; 7(1): 55-66.
57.    Chahar, D. Natural health products and good manufacturing practices. In Nutraceutical and Functional Food Regulations in the United States and around the World. 2019; (pp. 97-103). Academic Press.
58.    Abou-El-Enein, M., Römhild, A., Kaiser, D., Beier, C., Bauer, G., Volk, H. D., and Reinke, P. Good Manufacturing Practices (GMP) manufacturing of advanced therapy medicinal products: a novel tailored model for optimizing performance and estimating costs. Cytotherapy. 2013; 15(3): 362-383.
59.    Huynh‐Ba, K. (2022). Good Manufacturing Practices (GMPs) and Quality Systems. Analytical Testing for the Pharmaceutical GMP Laboratory, 26-56.
60.    Awang, D. V. Quality control and good manufacturing practices: Safety and efficacy of commercial herbals. Food and Drug Law Journal. 1997; 52(3): 341-344.
61.    Shukla, A., Vishnoi, G., and Das, D. R. Current good manufacturing guidelines for medicinal product. Journal of Drug Delivery and Therapeutics. 2016; 6(2), 57-61.
62.    Nelson, K. Facility design. Cell Culture Technology for Pharmaceutical and Cell-Based.2006; 553.
63.    Joseph, J. Facility design and process utilities. In Biopharmaceutical Processing. 2018; (pp. 933-986). Elsevier.
64.    Patel, K. T., and Chotai, N. P. Documentation and records: harmonized GMP requirements. Journal of Young Pharmacists. 2011; 3(2): 138-150.
65.    Roscioli, N. A. N. C. Y., and Vargo, S. U. S. A. N. Facility Design Issues-A Regulatory Perspective. Biotechnology and Bioprocessing Series. 2005; 29: 327.
66.    Keservani, R. K., Sharma, A. K., Ahmad, F., and Baig, M. E. Nutraceutical and functional food regulations in India. In Nutraceutical and functional food regulations in the United States and around the world.2014; (pp. 327-342). Academic Press.
67.    Sarma, N., Giancaspro, G., and Venema, J. Dietary supplements quality analysis tools from the United States Pharmacopeia. Drug Testing and Analysis. 2016; 8(3-4): 418-423.
68.    Jani, U. K. Good manufacturing practices (GMP): “Planning for quality and control in microbiology”. Frontier Discoveries and Innovations in Interdisciplinary Microbiology. 2016; 71-77.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank

Journal Policies & Information


Recent Articles




Tags


Not Available